May 31, 2024
Importation of Fresenius Kabi’s US-authorized Moxifloxacin Injection
Learn moreMay 31, 2024
Fighting Against Forced Labour and Child Labour in Supply Chains Act, S.C. 2023, c. 9 Annual Report
Learn moreJanuary 18, 2024
Medical Device Recall – Type III – IV Infusion Sets Label Discrepancy
Learn moreDecember 1, 2023
NEW! Now you can subscribe to our communications
Learn moreNovember 21, 2023
Fresenius Kabi Canada Holiday Schedule
Learn moreOctober 25, 2023
Fresenius Kabi Canada: Partners in Health with HPIC for 15 years
Learn moreSeptember 28, 2023
Elonox® is now available on every provincial formulary in Canada
Learn moreSeptember 19, 2023
Zinc Sulfate Injection, USP New Product Launch
Learn moreAugust 28, 2023
Sodium Citrate 4% solution, USP, 250mL – New Product Launch
Learn moreJuly 19, 2023
Now Available Fresenius Kabi’s newest biosimilar ELONOX® & ELONOX® HP (enoxaparin sodium)
Learn moreFebruary 23, 2023
Important Safety Information Sodium Acetate Injection, USP - Potential for the Development of Particulate Matter
Learn moreMay 17, 2022
Fentanyl Citrate Injection, USP 50 mcg/mL 20 mL SD Vial New Product Launch
Learn moreNovember 26, 2021
Fentanyl Citrate Injection, USP 50 mcg/mL New Product Launch
Learn moreSeptember 30, 2021
HYDROmorphone Hydrochloride Injection, USP 10 mg/mL 50 mL New Product Launch
Learn moreSeptember 7, 2021
Fresenius Kabi’s tocilizumab biosimilar candidate MSB11456 shows positive results in two clinical trials
Learn moreSeptember 2, 2021
Voriconazole for Injection 200 mg/vial New Product Launch
Learn moreJune 24, 2021
Vinorelbine Injection, USP 10 mg/mL 5 mL Vials Product Launch
Learn moreFebruary 27, 2021
Fresenius Kabi Biosimilars: providing affordable medicines when we need it the most
Learn moreFebruary 19, 2021
Fresenius Kabi Canada Launches IDACIO®
Learn moreDecember 19, 2020
Important Safety Information Bacitracin for Injection (50,000 IU per vial) – Risk of Nephrotoxicity and Anaphylactic Reactions
Learn moreAugust 28, 2020
2019 Canadian Hospital Pharmacist survey results
Learn moreJuly 13, 2020
DRUG RECALL – TYPE I – URGENT Dextrose 5% Injection 250ml
Learn moreMay 21, 2020
Fresenius Propoven 2% (Propofol 20 mg/mL SD Vial 100 mL)
Learn moreMay 16, 2020
DRUG RECALL – TYPE I – URGENT Penicillin G Sodium for Injection, USP
Learn moreMarch 30, 2020
Supporting our Canadian Customers and Continuity of Care
Learn moreFebruary 12, 2020
Morphine Sulfate Injection USP, Vials New Product Launch
Learn moreJanuary 31, 2020
Caspofungin For Injection Room-Temperature Vials New Product Launch
Learn moreOctober 23, 2019
Moxifloxacin Injection 1.6 mg/mL freeflex® Bag 250 mL Label Change Notice
Learn moreOctober 21, 2019
Shortage of Fludarabine Phosphate Injection and Replacement with US Labelled Stock Availability Notice
Learn moreSeptember 19, 2019
Sodium Bicarbonate Injection, USP New Product Launch
Learn moreApril 17, 2019
Bivalirudin for Injection 250 mg/vial 10 mL New Product Launch
Learn moreFebruary 27, 2019
Ropivacaine Hydrochloride Injection, USP 10mg/mL Ampoules NOW AVAILABLE!
Learn moreJanuary 9, 2019
SMOFlipid now available in 1000 mL Biofine bags in Canada!
Learn moreOctober 11, 2018
Fresenius Kabi Opens New Pharmaceutical Compounding Centre in Mississauga, Ontario
Learn moreSeptember 25, 2018
Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag New Product Launch
Learn moreJune 5, 2018
Parenteral Nutrition. Value of omega-3 fatty acids. Join the interactive webcast June 22, 2018
Learn moreSeptember 13, 2017
Announcing the launch of our new website
Learn moreSeptember 13, 2017
Announcing the launch of the new Fresenius Kabi Canada website
Learn moreAugust 21, 2017
Fresenius Kabi Canada Partners with HPIC to Improve Childbirth Health Outcomes in Haiti
Learn more- September 25 - 28, 2024
Canadian Surgery Forum
- October 25 - 26, 2024
CanVECTOR - Thrombosis Canada; Conference
- October 26 - 27, 2024